Outcomes of patients who underwent standard risk coronary artery bypass graft (CABG) surgery under the Philippine Health Insurance Corporation Z benefit package in a single private center in the Philippines.
- Author:
Maria Roussell Nennette TUÑACAO-SANDALO
1
;
Christie Ann VILLAREAL-INSO
1
;
Haidee YADAO
1
Author Information
- Publication Type:Journal Article, Original
- Keywords: Philippine Health Insurance Corporation; Philippine Health Insurance Z Benefit Package; Coronary Artery Bypass Graft; Whoqol-bref
- MeSH: Human; Coronary Artery Disease
- From: Philippine Journal of Cardiology 2025;53(1):12-31
- CountryPhilippines
- Language:English
-
Abstract:
BACKGROUND OF THE STUDY
Coronary artery disease (CAD) poses a significant global health challenge. In the Philippines, despite increased availability of coronary artery bypass grafting (CABG), cost remains a barrier to access. This research evaluates key factors such as all-cause death, cardiovascular death, repeat revascularization and quality of life post-CABG under the Philippine Health Z Benefit Package (PZBP). Its findings provide critical insights for shaping clinical practices, policymaking and advocating for broader implementation of the PZBP to improve healthcare access and quality of life for post-CABG patients.
METHODSThis retrospective cross-sectional study explores the outcomes of post-coronary artery bypass grafting (CABG) patients enrolled under the PZBP. The study, conducted at Perpetual Succour Hospital in Cebu City from December 2018 to September 2023, included patients diagnosed with CAD based on ACC/AHA 2021 guidelines. Using a complete enumeration strategy, the research employed descriptive statistics for demographic and clinical profiling, and measured quality of life using the World Health Organization Quality of Life Brief Version (WHOQOL-BREF) tool.
RESULTSThe study analyzed 29 patients who underwent CABG through the PZBP, presenting detailed demographic and clinical data. Most patients (41.4%) fell within the 51-60 age range, with males comprising 75.9%. Diabetes mellitus type II was prevalent (58.6%) and 86.2% had three-vessel diseases. The quality of life assessed with WHOQOL-BREF yielded positive scores across physical, mental, social and environmental domains, indicating favorable outcomes. Notably, no cardiovascular deaths, all-cause deaths, or repeat revascularizations were reported during the study, highlighting the effectiveness of CABG under PZBP.
CONCLUSIONThe study on post-CABG patients under the PZBP shows promising outcomes with no all-cause death, cardiovascular death, or repeat revascularization. This indicates the program's effectiveness in delivering accessible, high-quality healthcare, enhancing long-term survival rates and overall well-being. However, addressing underutilization is crucial, highlighting the importance of raising awareness and utilization to further improve post-CABG patients' outcomes and quality of life.
